Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Reply to Cheng and Chuang.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP.

Clin Infect Dis. 2019 Jan 30. doi: 10.1093/cid/ciz081. [Epub ahead of print] No abstract available.

PMID:
30715199
2.

Factors affecting the spatial and temporal distribution of E. coli in intertidal estuarine sediments.

Wyness AJ, Paterson DM, Mendo T, Defew EC, Stutter MI, Avery LM.

Sci Total Environ. 2019 Apr 15;661:155-167. doi: 10.1016/j.scitotenv.2019.01.061. Epub 2019 Jan 14.

PMID:
30669048
3.

Impact of a co-curricular, e-learning activity on pharmacy student knowledge of laboratory values.

Drayton SJ, Weeda ER, Avery LM, Penland B, Knight J.

Curr Pharm Teach Learn. 2019 Jan;11(1):87-93. doi: 10.1016/j.cptl.2018.10.001. Epub 2018 Oct 29.

PMID:
30527881
4.

In Vivo Efficacy of Humanized WCK 5222 (Cefepime-Zidebactam) Exposures against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Thigh Model.

Almarzoky Abuhussain SS, Avery LM, Abdelraouf K, Nicolau DP.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01931-18. doi: 10.1128/AAC.01931-18. Print 2019 Jan.

PMID:
30373797
5.

Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261-269].

Kidd JM, Avery LM, Asempa TE, Nicolau DP, Kuti JL.

Clin Ther. 2018 Nov;40(11):1956. doi: 10.1016/j.clinthera.2018.09.013. Epub 2018 Oct 16. No abstract available.

PMID:
30336952
6.

Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.

Avery LM, Kuti JL, Weisser M, Egli A, Rybak MJ, Zasowski EJ, Arias CA, Contreras GA, Chong PP, Aitken SL, DiPippo AJ, Wang JT, Britt NS, Nicolau DP.

Clin Infect Dis. 2018 Sep 5. doi: 10.1093/cid/ciy749. [Epub ahead of print]

PMID:
30188976
7.

Assessment of the In Vivo Efficacy of WCK 5222 (Cefepime-Zidebactam) against Carbapenem-Resistant Acinetobacter baumannii in the Neutropenic Murine Lung Infection Model.

Avery LM, Abdelraouf K, Nicolau DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00948-18. doi: 10.1128/AAC.00948-18. Print 2018 Nov.

PMID:
30181365
8.

Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.

Avery LM, Nicolau DP.

Int J Antimicrob Agents. 2018 Nov;52(5):688-691. doi: 10.1016/j.ijantimicag.2018.07.011. Epub 2018 Jul 22.

PMID:
30044946
9.

Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.

Asempa TE, Avery LM, Kidd JM, Kuti JL, Nicolau DP.

Am J Health Syst Pharm. 2018 Jul 15;75(14):1048-1056. doi: 10.2146/ajhp170839. Epub 2018 Jun 12.

PMID:
29895521
10.

The role of zeta potential in the adhesion of E. coli to suspended intertidal sediments.

Wyness AJ, Paterson DM, Defew EC, Stutter MI, Avery LM.

Water Res. 2018 Oct 1;142:159-166. doi: 10.1016/j.watres.2018.05.054. Epub 2018 May 29.

PMID:
29870949
11.

Characterization of Potentially Unsafe Ambulatory Antibiotic Use and Associated Outcomes in an Adult Kidney Transplant Population.

Avery LM, Fominaya CE, Crawford RC, Pleasants KP, Taber DJ.

Ann Pharmacother. 2018 Oct;52(10):974-982. doi: 10.1177/1060028018776606. Epub 2018 May 17.

PMID:
29770702
12.

Mitigating risk of bloodstream infection related to inpatient probiotic use.

Polito NB, Avery LM.

Am J Health Syst Pharm. 2018 May 15;75(10):595-596. doi: 10.2146/ajhp180092. No abstract available.

PMID:
29748296
13.

Feasibility of routine synergy testing using antibiotic gradient diffusion strips in the clinical laboratory.

Avery LM, Nicolau DP.

J Antimicrob Chemother. 2018 Aug 1;73(8):2264-2265. doi: 10.1093/jac/dky165. No abstract available.

PMID:
29746659
14.

Ciprofloxacin for the treatment of Cardiobacterium hominis prosthetic valve endocarditis.

Avery LM, Felberbaum CB, Hasan M.

IDCases. 2018 Feb 6;11:77-79. doi: 10.1016/j.idcr.2018.01.016. eCollection 2018.

15.

Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria.

Avery LM, Nicolau DP.

Expert Opin Investig Drugs. 2018 Apr;27(4):325-338. doi: 10.1080/13543784.2018.1460354. Epub 2018 Apr 10. Review.

PMID:
29611447
16.

Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site Administration.

Kidd JM, Avery LM, Asempa TE, Nicolau DP, Kuti JL.

Clin Ther. 2018 Feb;40(2):261-269. doi: 10.1016/j.clinthera.2017.12.007. Epub 2017 Dec 28. Erratum in: Clin Ther. 2018 Nov;40(11):1956.

PMID:
29290374
17.

Using spatial-stream-network models and long-term data to understand and predict dynamics of faecal contamination in a mixed land-use catchment.

Neill AJ, Tetzlaff D, Strachan NJC, Hough RL, Avery LM, Watson H, Soulsby C.

Sci Total Environ. 2018 Jan 15;612:840-852. doi: 10.1016/j.scitotenv.2017.08.151. Epub 2017 Sep 25.

PMID:
28881307
18.

Bipolar depression: Managing patients with second generation antipsychotics.

Avery LM, Drayton SJ.

Int J Psychiatry Med. 2016;51(2):145-59. doi: 10.1177/0091217416636576. Review.

PMID:
27079776
19.

Molecular tools for bathing water assessment in Europe: Balancing social science research with a rapidly developing environmental science evidence-base.

Oliver DM, Hanley ND, van Niekerk M, Kay D, Heathwaite AL, Rabinovici SJ, Kinzelman JL, Fleming LE, Porter J, Shaikh S, Fish R, Chilton S, Hewitt J, Connolly E, Cummins A, Glenk K, McPhail C, McRory E, McVittie A, Giles A, Roberts S, Simpson K, Tinch D, Thairs T, Avery LM, Vinten AJ, Watts BD, Quilliam RS.

Ambio. 2016 Feb;45(1):52-62. doi: 10.1007/s13280-015-0698-9. Epub 2015 Sep 21.

20.

Case of antibiotic-associated diarrhea caused by Staphylococcus aureus enterocolitis.

Avery LM, Zempel M, Weiss E.

Am J Health Syst Pharm. 2015 Jun 1;72(11):943-51. doi: 10.2146/ajhp140672.

PMID:
25987689
21.

Environmental risk factors in the incidence of Johne's disease.

Elliott GN, Hough RL, Avery LM, Maltin CA, Campbell CD.

Crit Rev Microbiol. 2015;41(4):488-507. doi: 10.3109/1040841X.2013.867830. Epub 2014 Mar 26. Review.

PMID:
24670062
22.

Clay mineral type effect on bacterial enteropathogen survival in soil.

Brennan FP, Moynihan E, Griffiths BS, Hillier S, Owen J, Pendlowski H, Avery LM.

Sci Total Environ. 2014 Jan 15;468-469:302-5. doi: 10.1016/j.scitotenv.2013.08.037. Epub 2013 Sep 12.

PMID:
24035982
23.

Criterion validity of the GMFM-66 item set and the GMFM-66 basal and ceiling approaches for estimating GMFM-66 scores.

Avery LM, Russell DJ, Rosenbaum PL.

Dev Med Child Neurol. 2013 Jun;55(6):534-8. doi: 10.1111/dmcn.12120. Epub 2013 Mar 1.

24.

Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole.

Avery LM, Steed ME, Woodruff AE, Hasan M, Rybak MJ.

Antimicrob Agents Chemother. 2012 Nov;56(11):5990-3. doi: 10.1128/AAC.01046-12. Epub 2012 Aug 6.

25.

Prevalence and survival of potential pathogens in source-segregated green waste compost.

Avery LM, Booth P, Campbell C, Tompkins D, Hough RL.

Sci Total Environ. 2012 Aug 1;431:128-38. doi: 10.1016/j.scitotenv.2012.05.020. Epub 2012 Jun 5. Review.

PMID:
22677624
26.

Risk assessment of the use of PAS100 green composts in sheep and cattle production in Scotland.

Hough RL, Booth P, Avery LM, Rhind S, Crews C, Bacon J, Campbell CD, Tompkins D.

Waste Manag. 2012 Jan;32(1):117-30. doi: 10.1016/j.wasman.2011.08.008. Epub 2011 Sep 15.

PMID:
21924890
27.

Using knowledge brokers to facilitate the uptake of pediatric measurement tools into clinical practice: a before-after intervention study.

Russell DJ, Rivard LM, Walter SD, Rosenbaum PL, Roxborough L, Cameron D, Darrah J, Bartlett DJ, Hanna SE, Avery LM.

Implement Sci. 2010 Nov 23;5:92. doi: 10.1186/1748-5908-5-92.

28.

Development and validation of item sets to improve efficiency of administration of the 66-item Gross Motor Function Measure in children with cerebral palsy.

Russell DJ, Avery LM, Walter SD, Hanna SE, Bartlett DJ, Rosenbaum PL, Palisano RJ, Gorter JW.

Dev Med Child Neurol. 2010 Feb;52(2):e48-54. doi: 10.1111/j.1469-8749.2009.03481.x. Epub 2009 Oct 7.

29.

Heat and lime-treatment as effective control methods for E. coli O157:H7 in organic wastes.

Avery LM, Williams AP, Killham K, Jones DL.

Bioresour Technol. 2009 May;100(10):2692-8. doi: 10.1016/j.biortech.2008.12.044. Epub 2009 Jan 31.

PMID:
19181517
30.

Leaching of bioluminescent Escherichia coli O157:H7 from sheep and cattle faeces during simulated rainstorm events.

Williams AP, Gordon H, Jones DL, Strachan NJ, Avery LM, Killham K.

J Appl Microbiol. 2008 Nov;105(5):1452-60. doi: 10.1111/j.1365-2672.2008.03898.x.

31.

Ultraviolet (UV) disinfection of grey water: particle size effects.

Winward GP, Avery LM, Stephenson T, Jefferson B.

Environ Technol. 2008 Feb;29(2):235-44. doi: 10.1080/09593330802030069.

PMID:
18613622
32.

Essential oils for the disinfection of grey water.

Winward GP, Avery LM, Stephenson T, Jefferson B.

Water Res. 2008 Apr;42(8-9):2260-8. doi: 10.1016/j.watres.2007.12.004. Epub 2007 Dec 15.

PMID:
18221769
33.

Survival of Escherichia coli O157:H7 in waters from lakes, rivers, puddles and animal-drinking troughs.

Avery LM, Williams AP, Killham K, Jones DL.

Sci Total Environ. 2008 Jan 25;389(2-3):378-85. Epub 2007 Oct 17.

PMID:
17920657
34.

Chlorine disinfection of grey water for reuse: effect of organics and particles.

Winward GP, Avery LM, Stephenson T, Jefferson B.

Water Res. 2008 Jan;42(1-2):483-91. Epub 2007 Jul 31.

PMID:
17904612
35.

Persistence, dissipation, and activity of Escherichia coli O157:H7 within sand and seawater environments.

Williams AP, Avery LM, Killham K, Jones DL.

FEMS Microbiol Ecol. 2007 Apr;60(1):24-32. Epub 2007 Jan 24.

36.

Survival of Escherichia coli O157:H7 in the rhizosphere of maize grown in waste-amended soil.

Williams AP, Avery LM, Killham K, Jones DL.

J Appl Microbiol. 2007 Feb;102(2):319-26.

37.

Earthworms as vectors of Escherichia coli O157:H7 in soil and vermicomposts.

Williams AP, Roberts P, Avery LM, Killham K, Jones DL.

FEMS Microbiol Ecol. 2006 Oct;58(1):54-64.

38.

Potential pitfalls in the quantitative molecular detection of Escherichia coli O157:H7 in environmental matrices.

Artz RR, Avery LM, Jones DL, Killham K.

Can J Microbiol. 2006 May;52(5):482-8.

PMID:
16699574
39.

Persistence of Escherichia coli O157 on farm surfaces under different environmental conditions.

Williams AP, Avery LM, Killham K, Jones DL.

J Appl Microbiol. 2005;98(5):1075-83.

40.

Survival of E. coli O157:H7 in organic wastes destined for land application.

Avery LM, Killham K, Jones DL.

J Appl Microbiol. 2005;98(4):814-22.

41.

Bacteriophages--potential for application in wastewater treatment processes.

Withey S, Cartmell E, Avery LM, Stephenson T.

Sci Total Environ. 2005 Mar 1;339(1-3):1-18. Review.

PMID:
15740754
42.

Rasch analysis of the Gross Motor Function Measure: validating the assumptions of the Rasch model to create an interval-level measure.

Avery LM, Russell DJ, Raina PS, Walter SD, Rosenbaum PL.

Arch Phys Med Rehabil. 2003 May;84(5):697-705.

PMID:
12736885
43.

Visual mechanisms of spatial disorientation in Alzheimer's disease.

O'Brien HL, Tetewsky SJ, Avery LM, Cushman LA, Makous W, Duffy CJ.

Cereb Cortex. 2001 Nov;11(11):1083-92. Erratum in: Cereb Cortex 2002 Jan;12(1):106.

PMID:
11590117
44.

Improved scaling of the gross motor function measure for children with cerebral palsy: evidence of reliability and validity.

Russell DJ, Avery LM, Rosenbaum PL, Raina PS, Walter SD, Palisano RJ.

Phys Ther. 2000 Sep;80(9):873-85.

PMID:
10960935
45.

Bioactive and immunoreactive variants of prolactin in milk and serum of lactating rats and their pups.

Kacsóh B, Veress Z, Tóth BE, Avery LM, Grosvenor CE.

J Endocrinol. 1993 Aug;138(2):243-57.

PMID:
8228733
47.

Molecular heterogeneity of prolactin in lactating rats and their pups: biological and immunological activities in pituitary gland, serum and milk.

Kacsóh B, Tóth BE, Avery LM, Yamamuro Y, Grosvenor CE.

Endocr Regul. 1991 Jun;25(1-2):98-110.

PMID:
1958841
48.

Rat milk inhibits the mitogenic response of Nb2 lymphoma cells to prolactin.

Tóth BE, Kacsóh B, Yamamuro Y, Avery LM, Grosvenor CE.

Endocr Regul. 1991 Jun;25(1-2):120-7.

PMID:
1958826
49.

Vale--Miss Daisy Bridges, CBE, RRC, SRN, SCM, FRSH.

Connor M, Avery LM, McLennan M.

UNA Nurs J. 1973 Jan-Feb;71:13-4. No abstract available.

PMID:
4487444
50.

Student nurses associations in Australia.

AVERY LM.

Am J Nurs. 1956 Feb;57(2):182-3. No abstract available.

PMID:
13381779

Supplemental Content

Loading ...
Support Center